Alector’s 71% drop prompts a fresh look at its valuation, financials, and pipeline to gauge recovery prospects amid lingering ...

While more research is needed, including human trials, the results are promising. The drug SW033291 could lead to a new type ...

Serotonin aside, eating nutrient-rich foods aren't a bad place to start if you're looking to feel better. To that end, we set ...

For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...

Lexington, Massachusetts Tuesday, July 22, 2025, 18:00 Hrs [IST] ...

CorestemChemon (KOSDAQ: 166480) is a full-service preclinical CRO with over two decades of experience in GLP-based toxicology ...

Repetitive reaching tasks in mature female rats triggered persistent pain-like and sickness behaviors linked to a surge in IL ...

Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery  SEOUL, South Korea, July 20, ...

A stem-cell-based "organ-on-a-chip" model of ALS mimics early biological changes seen in the degenerative disease.

Recent advances in glucose management are reshaping our understanding of cognitive decline and dementia prevention. Energy ...

Voyager Therapeutics Inc. has expanded its Alzheimer’s disease (AD) pipeline with the addition of a wholly owned program that ...